Gain Therapeutics (GANX)'s 30-day implied volatility (IV30) was 88.8% at the close on November 9, 2026, down from 189.6% the day before, against a 52-week range of 52.6% to 190.4%. Its 20-day historical volatility was 103.0%.
Data as of November 9, 2026.